曲妥珠单抗
乳腺癌
医学
肿瘤科
后天抵抗
癌症研究
癌症
泛素
内科学
生物
遗传学
基因
作者
Yutian Zou,Anli Yang,Bo Chen,Xinpei Deng,Jindong Xie,Danian Dai,Jinhui Zhang,Hailin Tang,Zhenhua Wu,Zhigang Zhou,Xiaoming Xie,Jin Wang
标识
DOI：10.1016/j.drup.2024.101126
摘要
With the wide application of trastuzumab deruxtecan (T-DXd), the survival of HER2-low breast cancer patients is dramatically improved. However, resistance to T-DXd still exists in a subset of patients, and the molecular mechanism remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI
不配.
Singularity
Leonardi
HEIKU
寻道图强
pcr163
坚强亦丝
完美的天空
iNk
一一
paparazzi221
Yziii
薰硝壤
豆豆
yufanhui
坚强的广山
8R60d8
不懈奋进
菠菜
好困
皖公网安备34019202002308
